JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

Search

Intuitive Surgical Inc

Gesloten

SectorGezondheidszorg

551.23 4.64

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

525.35

Max

552.26

Belangrijke statistieken

By Trading Economics

Inkomsten

-40M

664M

Verkoop

187M

2.4B

K/W

Sectorgemiddelde

62.123

37.461

Winstmarge

27.221

Werknemers

15,638

EBITDA

268M

987M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+16.06% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-21B

164B

Vorige openingsprijs

546.59

Vorige sluitingsprijs

551.23

Nieuwssentiment

By Acuity

23%

77%

127 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bearish Evidence

Intuitive Surgical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

21 okt 2025, 23:55 UTC

Populaire aandelen

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 okt 2025, 21:14 UTC

Winsten
Belangrijke Marktbewegers

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 okt 2025, 20:38 UTC

Winsten

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 jul 2025, 21:13 UTC

Winsten

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22 apr 2025, 20:55 UTC

Winsten

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

22 okt 2025, 15:42 UTC

Winsten

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 okt 2025, 12:34 UTC

Winsten

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 okt 2025, 11:49 UTC

Winsten

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 okt 2025, 20:08 UTC

Winsten

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 okt 2025, 20:08 UTC

Winsten

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 okt 2025, 20:05 UTC

Winsten

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 okt 2025, 20:05 UTC

Winsten

Intuitive Surgical 3Q Net $704.4M >ISRG

21 okt 2025, 20:05 UTC

Winsten

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 okt 2025, 20:05 UTC

Winsten

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 okt 2025, 20:05 UTC

Winsten

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 jul 2025, 20:14 UTC

Winsten

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 jul 2025, 20:13 UTC

Winsten

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 jul 2025, 20:13 UTC

Winsten

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q Net $658.4M >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q Rev $2.44B >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22 jul 2025, 20:05 UTC

Winsten

Intuitive Surgical 2Q EPS $1.81 >ISRG

22 apr 2025, 20:13 UTC

Winsten

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Net $698.4M >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 jan 2025, 21:17 UTC

Winsten

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

Peer Vergelijking

Prijswijziging

Intuitive Surgical Inc Prognose

Koersdoel

By TipRanks

16.06% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 611.68 USD  16.06%

Hoogste 685 USD

Laagste 440 USD

Gebaseerd op 20 Wall Street-analisten die 12-maands prijsdoelen bieden voor Intuitive Surgical Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

20 ratings

16

Buy

3

Hold

1

Sell

Technische score

By Trading Central

514.59 / 539.05Steun & Weerstand

Korte Termijn

Weak Bearish Evidence

Gemiddeld Termijn

Weak Bullish Evidence

Lange Termijn

Strong Bullish Evidence

Sentiment

By Acuity

127 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat